USFDA revokes authorization of COVID antibody drugs of GSK, Lilly and 2 others Ruchika Sharma24 Dec 2024 12:30 PM ISTThe US Food and Drug Administration (USFDA) has revoked the emergency use authorisation for four Covid-19 antibody-based drugs from pharma...
USFDA withdraws emergency use authorization for AstraZeneca COVID 19 treatment Evusheld Ruchika Sharma27 Jan 2023 4:42 PM ISTAstraZeneca said it was informed that the agency will decide about reinstating authorization of Evusheld if the prevalence of resistant variants in...
AstraZeneca Evusheld approved in EU for treatment of COVID Ruchika Sharma20 Sept 2022 2:30 PM ISTThe recommended dose of Evusheld for treatment in Europe is 300mg of tixagevimab and 300mg of cilgavimab, administered as two separate, sequential IM...
AstraZeneca Evusheld recommended for approval in EU for treatment of COVID-19 Ruchika Sharma17 Sept 2022 3:30 PM ISTThe recommended dose of Evusheld for treatment in the EU is 300mg of tixagevimab and 300mg of cilgavimab, administered as two separate, sequential IM...
AstraZeneca Covid jab Vaxzevria sales slide Ruchika Sharma1 Aug 2022 1:10 PM ISTThe group said annual revenue from Covid-19 medicines is anticipated to be broadly flat compared with 2021.
AstraZeneca Evusheld recommended for approval in EU for prevention of COVID Ruchika Sharma27 March 2022 9:30 AM ISTThe recommended dose of Evusheld in Europe is 150 mg of tixagevimab and 150mg of cilgavimab, administered as two separate sequential intramuscular...
AstraZeneca COVID drug Evusheld approved in Israel for people with weakened immune systems MD Bureau16 Feb 2022 10:07 AM ISTThe drug has been shown to reduce severe morbidity and mortality from Covid by 83 percent, it added.
AstraZeneca antibody cocktail Evusheld works against Omicron: USFDA study Ruchika Sharma18 Dec 2021 4:44 PM ISTNew Delhi: AstraZeneca has announced that Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination for the prevention of...
Health Bulletin 16/December/2021 Roshni Dhar16 Dec 2021 5:05 PM ISTHere are Top Health stories of the dayCriminal Medical Negligence Complaints May Not Be Entertained Without Credible Expert Opinion: Kerala...
AstraZeneca COVID antibody combination to be manufactured by Samsung Biologics MD Bureau15 Dec 2021 3:37 PM ISTSeoul: British-Swedish pharmaceutical giant AstraZeneca on Tuesday said that Samsung Biologics, the biotech arm of Samsung Group, will manufacture its...
Health Bulletin 10/December/2021 Roshni Dhar10 Dec 2021 4:29 PM ISTHere are Top Health stories of the dayDelay in Diagnosis Increases Severity of Condition: Kerala Hospital told to pay CompensationThe...
AstraZeneca in touch with Indian authorities for COVID drug Evusheld Ruchika Sharma10 Dec 2021 2:34 PM ISTEvusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US for COVID-19 pre-exposure...
